Lantern Pharma - Bathi resik saben saham sajrone 12 wulan pungkasan LTRN

Lantern Pharma Inc. (LTRN) is an IT-biotech startup developing AI-powered software to accelerate the discovery of anti-tumor drugs within the B2B segment. This price chart illustrates the EPS TTM trend, which currently stands at 9.80. Business growth is driven by the recruitment of leading bioinformaticians and engineers. The integration of digital systems with medical data enables the company to identify rare biomarkers for highly precise lung cancer therapy.
Lantern Pharma Inc. - rincian analitis lan metrik utama (LTRN)

Year-over-year EPS growth (TTM) measures the change in net income per share over a rolling year, reflecting the efficiency of the RADR AI platform in monetizing cancer biomarkers. The current value of 9.80 on this daily EPS TTM chart allows for a real-time assessment of the pricing power of Lantern Pharma Inc. (LTRN), although the indicator's peak points often signal a correction risk during a shift in the market cycle.